William Blair & Co.: Avid Bioservices, Inc. - Initiation of Research Coverage
September 29, 2023
September 29, 2023
CHICAGO, Illinois, Sept. 29 (TNSres) -- William Blair and Co., an investment bank and financial services company, issued the following news:
William Blair initiated research coverage of Avid Bioservices, Inc. (CDMO $10.01), a contract development and manufacturing organization (CDMO) focused on biologics drug substance manufacturing.
Analyst Max Smock estimated that the company, whose fiscal year ends in April, would generate revenue of $152.7 million in fiscal 2024 and . . .
William Blair initiated research coverage of Avid Bioservices, Inc. (CDMO $10.01), a contract development and manufacturing organization (CDMO) focused on biologics drug substance manufacturing.
Analyst Max Smock estimated that the company, whose fiscal year ends in April, would generate revenue of $152.7 million in fiscal 2024 and . . .